Capha Pharmaceuticals Inc. (FPSUF)
Capha Pharmaceuticals Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in West Kelowna, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $6,443. On trailing twelve-month figures it carries a trailing P/E of -0.46, a net margin of 0.0%. Its beta of 2.53 implies it has historically moved more than the broad market.
Capha Pharmaceuticals Inc. currently conducts very limited business operations. Its strategic aim is to delve into and pursue opportunities within the pharmaceutical distribution industry. The company, which was founded in 2004, previously operated as FPS Pharma Inc. until it adopted its present name, Capha Pharmaceuticals Inc., in January 2017. It is headquartered in West Kelowna, Canada.
Capha Pharmaceuticals Inc. is most often compared with the following Healthcare names: